--- title: "ASTRAZENECA UK LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/470a8049-6750-5b53-a977-dabd80cc8ebd json: https://whiteintel.dev/api/public/dossier/470a8049-6750-5b53-a977-dabd80cc8ebd identifier: oo:GB-COH-03674842 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # ASTRAZENECA UK LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-03674842` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/470a8049-6750-5b53-a977-dabd80cc8ebd **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/470a8049-6750-5b53-a977-dabd80cc8ebd ## Cross-source identity The same real-world entity, resolved across sources: - **Astrazeneca Uk Limited** — source · `gb-coh:3674842` — https://whiteintel.dev/entity/418262bf-abfc-4e8b-a8b4-6ecf5eb55d65 - **ASTRAZENECA UK LIMITED** — GLEIF · `lei:549300VDUBM78UTDVB73` — https://whiteintel.dev/entity/f04c0b1c-086b-5c9e-8df7-9d24d7de8e01 ## Ownership & control ### Owners / controllers - **ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/82b56cec-88e5-5450-932e-d4260d77f4df - **Astrazeneca Intermediate Holdings Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2ded1575-2225-4db4-8fe2-a7667e46d1b6 ### Holdings / subsidiaries - **ASTRAZENECA FINANCE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9db1a26d-e284-564e-a49b-859c5f9b7375 - **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff - **ASTRAZENECA INVESTMENTS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/239f0f3d-d24f-5c47-a298-6c6fcf8e8d7e - **ASTRAZENECA CHINA UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/76170439-de0c-5a44-91c3-10b9f9c9f730 - **ASTRAZENECA EMPLOYEE SHARE TRUST LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/ed44579c-3da6-51c0-8b51-f949e2202249 - **ASTRAZENECA QUEST LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/34c4295e-14f9-50e3-b7f5-2c74920fb903 - **ASTRAZENECA JAPAN LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/e08b34db-4cc1-50a1-92f6-6065033ea409 - **BRITISH PHARMA GROUP LIMITED** (beneficial owner) — 75% — https://whiteintel.dev/entity/44928f84-37a2-5b1a-adfe-0fffd0503bd8 - **ALDERLEY PARK VENTURES LIMITED** (beneficial owner) — https://whiteintel.dev/entity/67327502-ba91-5afd-b06a-1f297f4fd44f - **ASTRAZENECA NOMINEES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/7b01105e-accb-584c-a79b-db7939a811a0 - **ASTRAZENECA SHARE TRUST LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/ca4f99fe-9143-5788-b166-fdc5558cebbe - **EVINOVA LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/2d8f51d5-2063-50bb-846b-64791e3c0097 …and **6** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing. ### UBO chain (walk to the ultimate owner) A **4-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `03674842` - **Status:** active - **Type:** ltd - **Incorporated:** 1998-11-26 - **Registered office:** 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom - **SIC:** 70100 ### Officers - BOWDEN, Matthew Shaun — secretary · appointed 2025-05-01 - BRINDICCI, Caterina — director · Italian · appointed 2024-06-27 - COLLINS, Iain Alistair — director · British · appointed 2017-05-31 - DE GIORGIO-MILLER, Alexander — director · British · appointed 2024-06-27 - DOBBER, Rudi — director · Dutch · appointed 2024-06-27 - GALBRAITH, Susan — director · British · appointed 2024-06-27 - HARROP, Elaine — director · British · appointed 2024-06-27 - JERMUTUS, Lutz — director · British,German · appointed 2025-02-10 - SAMBROOK, Sally — director · British · appointed 2024-06-27 - SARIN, Aradhana — director · American · appointed 2021-08-02 - SORIOT, Pascal Claude Roland — director · French,Australian · appointed 2012-10-01 - STEPHENS, Christine — director · British · appointed 2024-06-27 - KEMP, Adrian Charles Noel — secretary · British · appointed 2009-01-01 · resigned 2025-05-01 - LONG, Julian Gerald — secretary · British · appointed 1998-12-03 · resigned 1999-04-01 - MUSKER, Graeme Harold Rankine — secretary · British · appointed 1999-04-01 · resigned 2008-12-31 - SWIFT INCORPORATIONS LIMITED — corporate nominee secretary · appointed 1998-11-26 · resigned 1998-12-03 - BRENNAN, David Richard — director · American · appointed 2006-01-01 · resigned 2012-06-01 - BRIMICOMBE, Ian Martin David — director · British · appointed 2013-05-18 · resigned 2017-05-31 - DUNOYER, Marc Pierre Jean — director · French · appointed 2013-11-29 · resigned 2021-09-20 - DUNOYER, Marc Pierre Jean — director · French · appointed 2013-11-01 · resigned 2013-11-01 ### Beneficial owners (Persons with Significant Control) - [Astrazeneca Intermediate Holdings Limited](https://whiteintel.dev/entity/2ded1575-2225-4db4-8fe2-a7667e46d1b6) — 75–100% shares · corporate PSC · England And Wales — since 2016-04-06 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/03674842 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/03674842 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **ASTRAZENECA UK LIMITED** — https://whiteintel.dev/entity/470a8049-6750-5b53-a977-dabd80cc8ebd · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **ASTRAZENECA UK LIMITED**. Human view: https://whiteintel.dev/entity/470a8049-6750-5b53-a977-dabd80cc8ebd · Structured JSON: https://whiteintel.dev/api/public/dossier/470a8049-6750-5b53-a977-dabd80cc8ebd._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._